Prosecution Insights
Last updated: July 17, 2026
Application No. 18/670,991

METHOD FOR REDUCING THE INCIDENCE OF PECTORAL MYOPATHY IN POULTRY FEED

Non-Final OA §102§103
Filed
May 22, 2024
Priority
Aug 24, 2017 — BR 102017018191.0 +2 more
Examiner
AFREMOVA, VERA
Art Unit
1653
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Can Technologies Inc.
OA Round
1 (Non-Final)
51%
Grant Probability
Moderate
1-2
OA Rounds
1y 5m
Est. Remaining
80%
With Interview

Examiner Intelligence

Grants 51% of resolved cases
51%
Career Allowance Rate
444 granted / 876 resolved
-9.3% vs TC avg
Strong +29% interview lift
Without
With
+29.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
53 currently pending
Career history
933
Total Applications
across all art units

Statute-Specific Performance

§101
6.5%
-33.5% vs TC avg
§103
78.0%
+38.0% vs TC avg
§102
5.9%
-34.1% vs TC avg
§112
1.5%
-38.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 876 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of the Group I, claims 1-16, in the reply filed on 4/16/2026 is acknowledged. Claims 17-18 have been withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 4/16/2026. Clams 1-16 are under examination in the instant office action. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1 -5 and 7-9 are rejected under 35 U.S.C. 102 (a) (1) as being anticipated by KR 748716 (Chang et al). The cited KR 748716 (Chang et al) discloses a fertilizer composition comprising: 1) calcium nitrates and 2) antioxidant polyphenols such as onion extract (see English abstract). The composition also comprises vitamins including vitamin C, amino acids and minerals including selenium, zinc, copper (col. 9 lines 34-36). Thus, the cited KR 748716 (Chang et al) clearly anticipates claims 1, 4, 5, 7 and 8. Further, claim 3 allows for the absence of nitrite. Claim 9 solely encompasses intended effects but not limited to any additional structural element. Thus, the cited KR 748716 (Chang et al) anticipates claimed product. Claims 1 and 3-9 are rejected under 35 U.S.C. 102 (a) (1) as being anticipated by US 10,967,002 (Van den Bosch et al). US 10,967,002 (Van den Bosch et al) discloses an animal feed composition comprising: 1) nitric oxide producing compounds that are nitrates and nitrites (see entire document including abstract and col. 1, lines 40-45) and antioxidants including flavonoids (col.11, line 19) that are major class of polyphenols. The composition is intended for various animals (col. 8, lines 63-64) including avian (col. 9, line 7). Nitrates and nitrites are salts of calcium, magnesium, ammonium, sodium (col. 3, lines 52-53; col.1, line 45). The amounts of nitrates in the total feeds are in the range less 1% or less than 0.2% (2,000 g per ton) or less than 0.05% (col. 5, lines 5-12) which overlaps the claimed range; and the feed is provided depending on animal weights and days of feeding (col. 4, lines 35-60). The composition also comprises vitamins including vitamin C and vitamin E (col. 9, lines 42-45), probiotics (col. 11, line 14) and minerals including selenium, zinc, manganese, copper (col. 9 lines 34-36). Thus, the cited US 10,967,002 (Van den Bosch et al) clearly anticipates claims 1, 4-8. Further, claim 3 allows for the absence of either nitrate or nitrite. Claim 9 is directed to intended effects. Thus, the cited US 10,967,002 (Van den Bosch et al) anticipates claimed product. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-16 are rejected under 35 U.S.C. 103 as being unpatentable over US 10,967,002 (Van den Bosch et al) taken with WO 2015/184311 (Hilbert et al). US 10,967,002 (Van den Bosch et al) discloses an animal feed composition comprising: 1) nitric oxide producing compounds that are nitrates and nitrites (see entire document including abstract and col. 1, lines 40-45); and 2) antioxidants including flavonoids (col. 11, line 19) that are major class of polyphenols. The composition is intended for various animals (col. 8, lines 63-64) including avian (col. 9, line 7). Nitrates and nitrites are salts of calcium, magnesium, ammonium, sodium (col. 3, lines 52-53; col.1, line 45). The amounts of nitrates in the total feeds are in the range less 1% or less than 0.2% (2,000 g per ton) or less than 0.05% (col. 5, lines 5-12) which overlaps the claimed range; and the feed is provided depending on animal weights and days of feeding (col. 4, lines 35-60). The composition also comprises vitamins including vitamin C and vitamin E (col. 9, lines 42-45), probiotics (col. 11, line 14) and minerals including selenium, zinc, manganese, copper (col. 9 lines 34-36). The cited US 10,967,002 (Van den Bosch et al) teaches an animal feed with nitrates/nitrites in a balanced diet feed comprising active agents including vitamins, minerals, antioxidants, flavonoids (claimed “polyphenol”) and phytochemicals (col. 11, lines 1-19; col. 9, line 28). But the disclosed phytochemicals-polyphenols are generic; and the cited document is silent about a specific source of phytochemicals, flavonoids or polyphenols as intended for animal diets including chicken diets. However, the prior art teaches beneficial incorporation of plant-derived phytochemicals or polyphenols such as a blend of grape seed extract, onion extract and rosemary extract for feeding poultry for increasing chicken performance. For example: see WO 2015/184311 at abstract, par. 0032, 0025, examples 1-9. The amounts of polyphenol source in complete feed varies from 1ppm to 300 ppm or 10-300 g per ton (par. 0038) which overlaps the claimed range. Therefore, it would have been obvious to one having ordinary skill in the art at the time the claimed invention was filed to use plant polyphenols derived from grape seed extract, onion extract and/or rosemary extract taught by WO 2015/184311 as the antioxidant-phytochemicals in the feed product of US 10,967,002 (Van den Bosch et al) with a reasonable expectation of success in providing a feed composition with beneficial effects on animal performance because US 10,967,002 (Van den Bosch et al) teaches and suggests animal health beneficial composition with nitrates/nitrites and polyphenol phytochemicals and because incorporation of plant-derived phytochemicals or polyphenols such as a blend of grape seed extract, onion extract and rosemary extract taught by WO 2015/184311 in the animal or avian feed provides for increasing animal and poultry performances. The idea of combining beneficial ingredients in the animal or poultry feed flows freely from the combined teachings of the prior art. Thus, the claimed invention as a whole was clearly prima facie obvious, especially in the absence of evidence to the contrary. The claimed subject matter fails to patentably distinguish over the state art as represented be the cited references. Therefore, the claims are properly rejected under 35 USC § 103. The claimed subject matter fails to patentably distinguish over the state art as represented be the cited references. Therefore, the claims are properly rejected under 35 USC § 103. Any inquiry concerning this communication or earlier communications from the examiner should be directed to VERA AFREMOVA whose telephone number is (571)272-0914. The examiner can normally be reached Monday-Friday: 8.30am-5pm EST. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sharmila Landau can be reached at (571) 272-0614. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Vera Afremova July 1, 2026 /VERA AFREMOVA/ Primary Examiner, Art Unit 1653
Read full office action

Prosecution Timeline

May 22, 2024
Application Filed
Jul 06, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12660736
SEED TREATMENT PROCESS FOR LARGE LIQUID VOLUMES
6y 5m to grant Granted Jun 23, 2026
Patent 12662656
LACTICASEIBACILLUS PARACASEI FMBL L23249 FJX AND USE THEREOF
1y 1m to grant Granted Jun 23, 2026
Patent 12648974
USE OF LACTOBACILLUS PARACASEI GM-080 FOR MODULATING IMMUNE FUNCTION
4y 3m to grant Granted Jun 09, 2026
Patent 12649945
DETECTION OF MYCOBACTERIUM ON GROWTH MEDIA
2y 6m to grant Granted Jun 09, 2026
Patent 12636316
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MYOSITIS, COMPRISING ISOLATED MITOCHONDRIA AS ACTIVE INGREDIENT
4y 7m to grant Granted May 26, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
51%
Grant Probability
80%
With Interview (+29.2%)
3y 7m (~1y 5m remaining)
Median Time to Grant
Low
PTA Risk
Based on 876 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month